C Page 82 and 83: Castiglioni S, Bagnati R, Fanelli R Page 84 and 85: Cevasco A, Urbatzka R, Bottero S, M Page 86 and 87: Chapman H
If you are underweight, using a healthy target weight helps you avoid undershooting your needs
Por qu la OPS emiti la alerta sobre agonistas GLP-1 Segn la OPS, en los ltimos meses varios pases han reportado eventos adversos de diversa gravedad vinculados al uso de medicamentos agonistas del receptor del pptido similar al glucagn-1 (GLP-1), entre ellos semaglutida, dulaglutida, liraglutida y tirzepatida, entre otros
Extension data show what happens when the drug is stopped: participants regained about 11.6% of their initial body weight within a year, underlining the reality that people may have to stay on the medication long-term